UCSD’s Catriona Jamieson and patient advocate Sandra Dillon at the CIRM Alpha Clinic Network Symposium Sometimes, when you take a moment to stand back and look at what you have accomplished, you can surprise yourself at how far you have come, and how much you have done in a short space of time. Take the … Continue reading Patients are the Heroes at the CIRM Alpha Stem Cell Clinics Symposium
Clinical Trials
Rare disease underdogs come out on top at CIRM Board meeting
It seems like an oxymoron but one in ten Americans has a rare disease. With more than 7,000 known rare diseases it’s easy to see how each one could affect thousands of individuals and still be considered a rare or orphan condition. Only 5% of rare diseases have FDA approved therapies People with rare … Continue reading Rare disease underdogs come out on top at CIRM Board meeting
CIRM Alpha Stem Cell Clinics: Paving a Path to Cures
Our mission at CIRM is to accelerate stem cell treatments to patients with unmet medical needs. Over the past ten years, our agency has been tasked with carefully distributing $3 billion dollars of California state tax payer money to the best and brightest scientists in California (and outside too, providing they meet certain requirements). These … Continue reading CIRM Alpha Stem Cell Clinics: Paving a Path to Cures
A TWIST in mesenchymal stem cell trials: protein predicts therapy’s potential
Mesenchymal stem cells are adult stem cells with the potential to specialize into a somewhat limited number of cell types – those responsible for making fat, bone and cartilage. But MSCs are also known for their anti-inflammatory properties which are carried out via the release of protein factors. This ability to dampen the immune system … Continue reading A TWIST in mesenchymal stem cell trials: protein predicts therapy’s potential
Stem cell stories that caught our eye: fighting cancer, a cell’s neighborhood matters, funding next generation scientists
Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. Reprogramming skin to fight cancer. Earlier CIRM-funded research showed that adult nerve stem cells can home to the residual brain cancer left behind after surgery … Continue reading Stem cell stories that caught our eye: fighting cancer, a cell’s neighborhood matters, funding next generation scientists
If you want to accelerate stem cell therapies then create an Accelerating Center
“You can’t teach fish to fly,” is one of the phrases that our CIRM President & CEO, Randy Mills, likes to throw out when asked why we needed to create new centers to help researchers move their most promising therapies out of the lab and into clinical trials. His point is that many researchers are … Continue reading If you want to accelerate stem cell therapies then create an Accelerating Center
Patients beware: warnings about shady clinics and suspect treatments
Every day we get a call from someone seeking help. Some are battling a life-threatening or life-changing disease. Others call on behalf of a friend or loved one. All are looking for the same thing; a treatment, better still a cure, to ease their suffering. Almost every day we have to tell them the same … Continue reading Patients beware: warnings about shady clinics and suspect treatments
New Stem Cell Treatment for ALS May Slow Disease Progression
Exciting news was published this week that will give patients suffering from ALS, also known as Lou Gehrig’s disease, something to cheer about. The journal JAMA Neurology reported that a new stem cell treatment was successful in slowing disease progression in a small group of ALS patients in a Phase 2 clinical trial. This is … Continue reading New Stem Cell Treatment for ALS May Slow Disease Progression
What Went Down at ARM’s Regenerative Medicine State of the Industry
Every January, downtown San Francisco is taken over by a flock of investors, bankers, biotech companies, and scientists attending the annual JP Morgan Healthcare Conference. This meeting looks at the healthcare advancements over the past year and predicts the disease areas and technologies that will see the most progress and success in 2016. According to … Continue reading What Went Down at ARM’s Regenerative Medicine State of the Industry
National honor for helping “the blind see”
Those of us fortunate to have good health take so many things for granted, not the least of which is our ability to see. But, according to the World Health Organization, there are 39 million people worldwide who are blind, and another 246 million who are visually impaired. Any therapy, any device, that can help … Continue reading National honor for helping “the blind see”
The Stem Cellar 